{"id":355496,"date":"2026-11-19T15:09:03","date_gmt":"2026-11-19T09:39:03","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=355496"},"modified":"2026-11-19T15:09:03","modified_gmt":"2026-11-19T09:39:03","slug":"metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/","title":{"rendered":"Metropolis Healthcare Share Price: 11.8% CAGR in 3 Years as the Mumbai-Based Pathology Chain Compares With Dr Lal PathLabs, Fortis Healthcare and Narayana Health"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#Metropolis_Healthcare_Share_Price_118_CAGR_in_3_Years_as_the_Mumbai-Based_Pathology_Chain_Compares_With_Dr_Lal_PathLabs_Fortis_Healthcare_and_Narayana_Health\" title=\"Metropolis Healthcare Share Price: 11.8% CAGR in 3 Years as the Mumbai-Based Pathology Chain Compares With Dr Lal PathLabs, Fortis Healthcare and Narayana Health\">Metropolis Healthcare Share Price: 11.8% CAGR in 3 Years as the Mumbai-Based Pathology Chain Compares With Dr Lal PathLabs, Fortis Healthcare and Narayana Health<\/a><ul class='ez-toc-list-level-2' ><li class='ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#How_Much_Has_the_Metropolis_Healthcare_Share_Price_Returned_in_3_Years\" title=\"How Much Has the Metropolis Healthcare Share Price Returned in 3 Years?\">How Much Has the Metropolis Healthcare Share Price Returned in 3 Years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#Metropolis_Healthcare_vs_Dr_Lal_PathLabs_Fortis_Healthcare_and_Narayana_Health_3-Year_CAGR_Compared\" title=\"Metropolis Healthcare vs Dr Lal PathLabs, Fortis Healthcare and Narayana Health: 3-Year CAGR Compared\">Metropolis Healthcare vs Dr Lal PathLabs, Fortis Healthcare and Narayana Health: 3-Year CAGR Compared<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#Valuation_and_Quality_Compared\" title=\"Valuation and Quality Compared\">Valuation and Quality Compared<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#What_Is_Driving_the_Metropolis_Healthcare_Stock\" title=\"What Is Driving the Metropolis Healthcare Stock?\">What Is Driving the Metropolis Healthcare Stock?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#How_the_Established_Players_Stack_Up\" title=\"How the Established Players Stack Up\">How the Established Players Stack Up<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#What_Should_Investors_Track_Next\" title=\"What Should Investors Track Next?\">What Should Investors Track Next?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#How_to_Compare_Diagnostics_Stocks_Yourself\" title=\"How to Compare Diagnostics Stocks Yourself\">How to Compare Diagnostics Stocks Yourself<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#A_Focused_Lab_Chain_Beside_Larger_Healthcare_Names\" title=\"A Focused Lab Chain Beside Larger Healthcare Names\">A Focused Lab Chain Beside Larger Healthcare Names<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#What_is_the_Metropolis_Healthcare_share_price_today\" title=\"What is the Metropolis Healthcare share price today?\">What is the Metropolis Healthcare share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#What_is_the_3-year_CAGR_of_the_Metropolis_Healthcare_stock\" title=\"What is the 3-year CAGR of the Metropolis Healthcare stock?\">What is the 3-year CAGR of the Metropolis Healthcare stock?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#Is_Metropolis_Healthcare_better_than_Dr_Lal_PathLabs\" title=\"Is Metropolis Healthcare better than Dr Lal PathLabs?\">Is Metropolis Healthcare better than Dr Lal PathLabs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#What_does_Metropolis_Healthcare_do\" title=\"What does Metropolis Healthcare do?\">What does Metropolis Healthcare do?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#Is_the_Metropolis_Healthcare_stock_debt_free\" title=\"Is the Metropolis Healthcare stock debt free?\">Is the Metropolis Healthcare stock debt free?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#Is_Metropolis_Healthcare_expensive_compared_with_the_industry\" title=\"Is Metropolis Healthcare expensive compared with the industry?\">Is Metropolis Healthcare expensive compared with the industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#Which_diagnostics_stock_gave_the_highest_return_in_3_years\" title=\"Which diagnostics stock gave the highest return in 3 years?\">Which diagnostics stock gave the highest return in 3 years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/metropolis-healthcare-share-price-3-year-cagr-vs-diagnostic-labs-peers-dr-lal-fortis-narayana-health\/#How_do_I_calculate_CAGR_for_a_stock\" title=\"How do I calculate CAGR for a stock?\">How do I calculate CAGR for a stock?<\/a><\/li><\/ul><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h1><span class=\"ez-toc-section\" id=\"Metropolis_Healthcare_Share_Price_118_CAGR_in_3_Years_as_the_Mumbai-Based_Pathology_Chain_Compares_With_Dr_Lal_PathLabs_Fortis_Healthcare_and_Narayana_Health\"><\/span><strong>Metropolis Healthcare Share Price: 11.8% CAGR in 3 Years as the Mumbai-Based Pathology Chain Compares With Dr Lal PathLabs, Fortis Healthcare and Narayana Health<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h1>\n<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Metropolis Healthcare previous close Rs 564.30. 3-year CAGR 11.8%. Up 1.4x since 17 Nov 2023. ROE 13.66%. Market cap Rs 11,704 crore.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The <strong>Metropolis Healthcare share price<\/strong> closed at Rs 564.30 on 18 November 2026, a compounded annual return of <strong>11.8%<\/strong> over three years. That compares with Dr Lal PathLabs at 13.4%, Fortis Healthcare at 30.6% and Narayana Health at 15.5%. The company has a <strong>market cap<\/strong> of Rs 11,704 crore and a P\/E of 51.93 against an industry P\/E of 63.96.<\/p>\n<\/p><\/div>\n<p>The <strong>Metropolis Healthcare share price<\/strong> closed at Rs 564.30 on 18 November 2026 and has compounded at <strong>11.8%<\/strong> a year over three years. Metropolis Healthcare, based in Mumbai, runs a network of <strong>pathology labs<\/strong>, collection centres and <strong>home collection<\/strong> services in India and abroad.<\/p>\n<p>This article places that return beside Dr Lal PathLabs, Fortis Healthcare and Narayana Health. We calculate the <strong>three-year CAGR<\/strong> for all four and set the results next to market cap, valuation, <strong>return on equity<\/strong> and debt, using prices adjusted for corporate actions.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=metropolis-healthcare-share-price\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Much_Has_the_Metropolis_Healthcare_Share_Price_Returned_in_3_Years\"><\/span><strong>How Much Has the Metropolis Healthcare Share Price Returned in 3 Years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Metropolis Healthcare stock<\/strong> closed at Rs 404.35 on 17 November 2023 and at Rs 564.30 on 18 November 2026. Rs 1 lakh invested three years ago would have grown to about Rs 1.40 lakh, which is a <strong>CAGR<\/strong> of <strong>11.8%<\/strong>. This is a price return and leaves out dividends.<\/p>\n<p>CAGR condenses a bumpy three-year ride into one yearly number, which is why it is the fairest way to compare companies of different sizes. A stock such as Metropolis Healthcare can look spectacular on a chart and still have earned a modest yearly return, so the compounded figure keeps the comparison honest.<\/p>\n<p>A diagnostics business grows when more patients are tested and when each patient takes more tests. The <strong>Metropolis Healthcare share price<\/strong> follows that volume and mix story, with a modest price return alongside a light balance sheet.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Metropolis_Healthcare_vs_Dr_Lal_PathLabs_Fortis_Healthcare_and_Narayana_Health_3-Year_CAGR_Compared\"><\/span><strong>Metropolis Healthcare vs Dr Lal PathLabs, Fortis Healthcare and Narayana Health: 3-Year CAGR Compared<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table ranks the companies by three-year CAGR. Prices on 17 November 2023 are adjusted for splits and bonuses, and the latest figures are the previous close on 18 November 2026.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:14px 0;\">\n<tr>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Company<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Close on 17 Nov 2023<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Previous close (18 Nov 2026)<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Price multiple<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">3-year CAGR<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Fortis Healthcare<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 356.30<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 793.55<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">2.2x<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">30.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Narayana Health<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,225.90<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,891.30<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">1.5x<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">15.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Dr Lal PathLabs<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,349.38<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 1,965.40<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">1.5x<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">13.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Metropolis Healthcare<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 404.35<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 564.30<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">1.4x<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">11.8%<\/td>\n<\/tr>\n<\/table>\n<p>The <strong>Metropolis Healthcare stock<\/strong> ranks fourth of the four at <strong>11.8%<\/strong>. The companies ahead are Fortis Healthcare (30.6%), Narayana Health (15.5%) and Dr Lal PathLabs (13.4%). By market cap the company ranks fourth of the four at Rs 11,704 crore. Fortis Healthcare is the largest of the four by market cap, and Metropolis is the smallest, so the comparison shows how a focused lab chain sits beside larger healthcare names.<\/p>\n<p>Look at the <strong>Metropolis Healthcare share price<\/strong> alongside the peers as a snapshot of the last three years. It describes what happened, and valuation and earnings will decide what happens next.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Valuation_and_Quality_Compared\"><\/span><strong>Valuation and Quality Compared<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:14px 0;\">\n<tr>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Company<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Market cap<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">P\/E<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #bbb;padding:6px 10px;background:#EBF3FB;text-align:left;\">Debt to equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\"><a href=\"https:\/\/univest.in\/stocks\/fortis\/fortis-healthcare-ltd-share-price-today\">Fortis Healthcare<\/a><\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 60,170 crore<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">56.65<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">63.96<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">9.91%<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">0.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Narayana Health<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 38,635 crore<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">44.97<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">63.96<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">17.17%<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">1.21<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\"><a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr Lal PathLabs<\/a><\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 32,976 crore<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">56.08<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">63.96<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">21.32%<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">0.09<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\"><a href=\"https:\/\/univest.in\/stocks\/metropolis\/metropolis-healthcare-ltd-share-price-today\">Metropolis Healthcare<\/a><\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">Rs 11,704 crore<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">51.93<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">63.96<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">13.66%<\/td>\n<td style=\"border:1px solid #bbb;padding:6px 10px;\">0.16<\/td>\n<\/tr>\n<\/table>\n<p>By market cap, Fortis Healthcare is the largest of the group at Rs 60,170 crore, while the Metropolis Healthcare stock stands at Rs 11,704 crore, about 19% of that size. On earnings, Metropolis Healthcare shares trade at a P\/E of 51.93 against an industry P\/E of 63.96, a discount of about 19% to the sector, which leaves room if earnings keep growing. Peer multiples are Dr Lal PathLabs at 56.08, Fortis Healthcare at 56.65 and Narayana Health at 44.97.<\/p>\n<p>Return on equity is 13.66% for the Metropolis Healthcare stock, which ranks third among the four, and <strong>debt to equity<\/strong> stands at 0.16. Trailing EPS is Rs 10.86. Metropolis trades at a P\/E of 51.93 against an industry P\/E of 63.96, with a price to book of 7.13. That makes it the second lowest P\/E in the group.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_Driving_the_Metropolis_Healthcare_Stock\"><\/span><strong>What Is Driving the Metropolis Healthcare Stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Metropolis earns revenue from routine tests, <strong>specialised tests<\/strong> and wellness packages sold through labs, collection centres and partner hospitals. Specialised tests carry higher realisation than routine ones.<\/p>\n<p>The company earns an ROE of 13.66% and carries a debt to equity of just 0.16, which is the third highest in the group. Its P\/E of 51.93 sits below the industry P\/E of 63.96.<\/p>\n<p>Investors who follow the <strong>Metropolis Healthcare share price<\/strong> usually track test volumes, revenue per patient, the share of specialised tests and operating margin.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_the_Established_Players_Stack_Up\"><\/span><strong>How the Established Players Stack Up<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr Lal PathLabs is a Delhi-based diagnostics company with a large network of labs and collection centres. It compounded at 13.4% a year, on a market cap of Rs 32,976 crore and an ROE of 21.32%.<\/p>\n<p>Fortis Healthcare is a Gurugram-based hospital chain with a diagnostics arm and hospitals in many cities. It compounded at 30.6% a year, on a market cap of Rs 60,170 crore and an ROE of 9.91%.<\/p>\n<p>Narayana Health is a Bengaluru-based hospital chain known for its cardiac care. It compounded at 15.5% a year, on a market cap of Rs 38,635 crore and an ROE of 17.17%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Should_Investors_Track_Next\"><\/span><strong>What Should Investors Track Next?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Three things are worth watching on the <strong>Metropolis Healthcare share price<\/strong>. First, test volume growth in the next quarterly result. Second, the share of specialised tests in revenue. Third, operating margin as the network expands.<\/p>\n<p>At a P\/E of 51.93 the stock trades below the industry P\/E of 63.96, which leaves room if volumes keep growing. Lab pricing is competitive, so follow each result closely.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live fundamentals of diagnostics stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Compare_Diagnostics_Stocks_Yourself\"><\/span><strong>How to Compare Diagnostics Stocks Yourself<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>You can repeat this exercise for any pair of stocks, including the Metropolis Healthcare stock against its peers. Note the adjusted closing price on the base date, take the latest close, divide one by the other, raise the result to the power of one third and subtract one. Then place the CAGR next to market cap, P\/E against the industry P\/E, ROE and debt to equity. Benchmark the result against the <a href=\"https:\/\/univest.in\/indices\/nifty-50\/nifty-50-share-price-today\">Nifty 50<\/a> as well, so you know whether the stock beat the broader market.<\/p>\n<p>A stock that scores well on growth but weakly on quality, or the reverse, deserves closer study before it enters a portfolio. When tracking the <strong>Metropolis Healthcare share price<\/strong>, the same four checks give a more complete picture than price alone.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track the <strong>Metropolis Healthcare share price<\/strong> and compare diagnostics stocks live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"A_Focused_Lab_Chain_Beside_Larger_Healthcare_Names\"><\/span><strong>A Focused Lab Chain Beside Larger Healthcare Names<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Metropolis Healthcare share price<\/strong> compounded at 11.8% a year over three years, against 30.6% for Fortis, 15.5% for Narayana Health and 13.4% for Dr Lal PathLabs. Its market cap is Rs 11,704 crore.<\/p>\n<p>Fortis Healthcare brings the fastest return, Dr Lal PathLabs brings the highest ROE and Narayana Health brings the lowest P\/E. Metropolis offers a pure diagnostics model with low debt.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Metropolis_Healthcare_share_price_today\"><\/span><strong>What is the Metropolis Healthcare share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Metropolis Healthcare closed at Rs 564.30 on 18 November 2026, according to NSE data. It has a market cap of Rs 11,704 crore and a P\/E of 51.93. Check live quotes before acting, as prices change every trading day.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_3-year_CAGR_of_the_Metropolis_Healthcare_stock\"><\/span><strong>What is the 3-year CAGR of the Metropolis Healthcare stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Metropolis Healthcare delivered a price CAGR of 11.8% over three years, moving from Rs 404.35 on 17 November 2023 to Rs 564.30 on 18 November 2026. The figure excludes dividends and uses adjusted closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Metropolis_Healthcare_better_than_Dr_Lal_PathLabs\"><\/span><strong>Is Metropolis Healthcare better than Dr Lal PathLabs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr Lal PathLabs delivered the higher three-year CAGR at 13.4% against 11.8% for Metropolis Healthcare. Dr Lal PathLabs has the larger market cap at Rs 32,976 crore against Rs 11,704 crore for Metropolis Healthcare. Dr Lal PathLabs earns the higher ROE at 21.32% against 13.66%. Metropolis Healthcare trades at the lower P\/E of 51.93 against 56.08. The better choice depends on whether you weigh recent return, size, profitability or valuation most.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Metropolis_Healthcare_do\"><\/span><strong>What does Metropolis Healthcare do?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Metropolis Healthcare Limited is a Mumbai-based diagnostics company that operates pathology laboratories, collection centres and home sample collection services.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_the_Metropolis_Healthcare_stock_debt_free\"><\/span><strong>Is the Metropolis Healthcare stock debt free?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The debt to equity ratio of the Metropolis Healthcare stock is 0.16 and its return on equity is 13.66%. Always check the latest balance sheet for current figures, as debt levels change with expansion plans.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Metropolis_Healthcare_expensive_compared_with_the_industry\"><\/span><strong>Is Metropolis Healthcare expensive compared with the industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Metropolis Healthcare trades at a P\/E of 51.93 against an industry P\/E of 63.96. A higher multiple reflects expectations of faster growth, which the company must deliver through earnings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_diagnostics_stock_gave_the_highest_return_in_3_years\"><\/span><strong>Which diagnostics stock gave the highest return in 3 years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Among the companies compared here, Fortis Healthcare delivered the highest three-year CAGR at 30.6%, followed by Narayana Health at 15.5%. Past returns do not guarantee future performance.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_I_calculate_CAGR_for_a_stock\"><\/span><strong>How do I calculate CAGR for a stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divide the latest price by the starting price, raise the result to the power of one divided by the number of years, and subtract one. Multiply by 100 for a percentage. Use split and bonus adjusted prices for accurate results.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Metropolis Healthcare share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Metropolis Healthcare closed at Rs 564.30 on 18 November 2026, according to NSE data. It has a market cap of Rs 11,704 crore and a P\/E of 51.93. Check live quotes before acting, as prices change every trading day.\"}},{\"@type\":\"Question\",\"name\":\"What is the 3-year CAGR of the Metropolis Healthcare stock?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Metropolis Healthcare delivered a price CAGR of 11.8% over three years, moving from Rs 404.35 on 17 November 2023 to Rs 564.30 on 18 November 2026. The figure excludes dividends and uses adjusted closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Is Metropolis Healthcare better than Dr Lal PathLabs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr Lal PathLabs delivered the higher three-year CAGR at 13.4% against 11.8% for Metropolis Healthcare. Dr Lal PathLabs has the larger market cap at Rs 32,976 crore against Rs 11,704 crore for Metropolis Healthcare. Dr Lal PathLabs earns the higher ROE at 21.32% against 13.66%. Metropolis Healthcare trades at the lower P\/E of 51.93 against 56.08. The better choice depends on whether you weigh recent return, size, profitability or valuation most.\"}},{\"@type\":\"Question\",\"name\":\"What does Metropolis Healthcare do?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Metropolis Healthcare Limited is a Mumbai-based diagnostics company that operates pathology laboratories, collection centres and home sample collection services.\"}},{\"@type\":\"Question\",\"name\":\"Is the Metropolis Healthcare stock debt free?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The debt to equity ratio of the Metropolis Healthcare stock is 0.16 and its return on equity is 13.66%. Always check the latest balance sheet for current figures, as debt levels change with expansion plans.\"}},{\"@type\":\"Question\",\"name\":\"Is Metropolis Healthcare expensive compared with the industry?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Metropolis Healthcare trades at a P\/E of 51.93 against an industry P\/E of 63.96. A higher multiple reflects expectations of faster growth, which the company must deliver through earnings.\"}},{\"@type\":\"Question\",\"name\":\"Which diagnostics stock gave the highest return in 3 years?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Among the companies compared here, Fortis Healthcare delivered the highest three-year CAGR at 30.6%, followed by Narayana Health at 15.5%. Past returns do not guarantee future performance.\"}},{\"@type\":\"Question\",\"name\":\"How do I calculate CAGR for a stock?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divide the latest price by the starting price, raise the result to the power of one divided by the number of years, and subtract one. Multiply by 100 for a percentage. Use split and bonus adjusted prices for accurate results.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Metropolis Healthcare share price compounded at 11.8% a year over 3 years. See how it compares with peers on returns and valuation.<\/p>\n","protected":false},"author":34,"featured_media":355495,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[26365,26366,26368,26367],"class_list":["post-355496","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-diagnostics-stocks-3-year-return","tag-metropolis-healthcare-share-price","tag-metropolis-healthcare-stock","tag-metropolis-vs-dr-lal-pathlabs"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["355495"],"rank_math_title":["Metropolis Healthcare Share Price: 11.8% CAGR in 3 Years"],"rank_math_description":["Metropolis Healthcare share price compounded at 11.8% a year over 3 years. See how it compares with peers on returns and valuation."],"rank_math_focus_keyword":["Metropolis Healthcare share price | Density Target: 1.2-1.5%"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/metropolis-healthcare-share-price-11-8-cagr-in-3-years-as-the-mumbai-based.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/355496","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=355496"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/355496\/revisions"}],"predecessor-version":[{"id":355497,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/355496\/revisions\/355497"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/355495"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=355496"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=355496"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=355496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}